Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2024 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 38.16% | 38.16% | 72.43% | ||
| Total Depreciation and Amortization | -18.37% | -18.37% | 0.00% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 52.17% | 52.17% | -136.81% | ||
| Change in Net Operating Assets | 25.24% | 25.24% | -27.30% | ||
| Cash from Operations | 38.88% | 38.88% | 17.13% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -47.22% | -47.22% | -17.24% | ||
| Cash from Investing | -47.22% | -47.22% | -17.24% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -9.09% | -9.09% | 4.35% | ||
| Issuance of Common Stock | 72.47% | 72.47% | 348.94% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -7.34% | -7.34% | -316.47% | ||
| Cash from Financing | 84.58% | 84.58% | 392.84% | ||
| Foreign Exchange rate Adjustments | -100.00% | -100.00% | 160.00% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 280.76% | 280.76% | 68.62% | ||